Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Marcellin

Showing results (171-180 of 212) with videos related to

Pageof 22
Sort By:
Annals of Internal Medicine|February 12, 1998
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapyP Marcellin, N Boyer, A Gervais, et al.
Hepatology (Baltimore, Md.)|September 19, 2000
A la carte interferon for hepatitis C?P Marcellin, J P Benhamou, J Heathcote, et al.
Bone Marrow Transplantation|August 3, 2005
Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipientsR Peffault de Latour, T Asselah, V Lévy, et al.
Hepatology (Baltimore, Md.)|December 4, 2001
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort studyV Di Martino, P Rufat, N Boyer, et al.
Annals of Internal Medicine|June 1, 1997
Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis CM Martinot, P Marcellin, N Boyer, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatmentD C Valla, M Chevallier, P Marcellin, et al.
Journal of Hepatology|July 25, 2000
Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseasesR Tuveri, F Jaffredo, F Lunel, et al.
Hepatology (Baltimore, Md.)|July 1, 1999
Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP)V Carreño, P Marcellin, S Hadziyannis, et al.
British Journal of Clinical Pharmacology|June 26, 2001
Influence of cirrhosis on lamotrigine pharmacokineticsP Marcellin, F de Bony, C Garret, et al.
Hepatology (Baltimore, Md.)|March 30, 1999
Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual menJ F Colin, D Cazals-Hatem, M A Loriot, et al.
Pageof 22

Showing results (171-180 of 212) with videos related to

Sort By:
Pageof 22
Annals of Internal Medicine|February 12, 1998
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapyP Marcellin, N Boyer, A Gervais, et al.
Hepatology (Baltimore, Md.)|September 19, 2000
A la carte interferon for hepatitis C?P Marcellin, J P Benhamou, J Heathcote, et al.
Bone Marrow Transplantation|August 3, 2005
Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipientsR Peffault de Latour, T Asselah, V Lévy, et al.
Hepatology (Baltimore, Md.)|December 4, 2001
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort studyV Di Martino, P Rufat, N Boyer, et al.
Annals of Internal Medicine|June 1, 1997
Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis CM Martinot, P Marcellin, N Boyer, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatmentD C Valla, M Chevallier, P Marcellin, et al.
Journal of Hepatology|July 25, 2000
Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseasesR Tuveri, F Jaffredo, F Lunel, et al.
Hepatology (Baltimore, Md.)|July 1, 1999
Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP)V Carreño, P Marcellin, S Hadziyannis, et al.
British Journal of Clinical Pharmacology|June 26, 2001
Influence of cirrhosis on lamotrigine pharmacokineticsP Marcellin, F de Bony, C Garret, et al.
Hepatology (Baltimore, Md.)|March 30, 1999
Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual menJ F Colin, D Cazals-Hatem, M A Loriot, et al.
Pageof 22